Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

This resolution advocates for the designation of September 30, 2025, as "Rare Cancer Day" to bring attention to the significant challenges encountered by individuals diagnosed with rare cancers. It emphasizes that approximately one in five cancer patients in the United States has a rare cancer, and these cancers account for a quarter of all cancer deaths annually, often presenting with lower five-year survival rates compared to more common cancers. The resolution highlights that early detection and effective treatment for rare cancers are particularly difficult due to a lack of awareness regarding symptoms among patients and clinicians, leading to delayed diagnoses. It underscores the limited scientific understanding and treatment options currently available for many rare cancers, which further exacerbates patient outcomes. To address these issues, the House of Representatives supports increasing awareness of rare cancer symptoms to facilitate earlier detection and improve survival rates. Furthermore, it encourages partnerships within the medical and scientific communities to advance early diagnosis and develop effective treatments, while also advocating for dedicated funding to explore cures and therapies for these challenging diseases.